DIA Stock Overview
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
DiaSorin S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €97.56 |
| 52 Week High | €143.80 |
| 52 Week Low | €94.28 |
| Beta | 0.13 |
| 1 Month Change | -0.93% |
| 3 Month Change | -12.11% |
| 1 Year Change | -20.36% |
| 3 Year Change | -45.47% |
| 5 Year Change | 10.55% |
| Change since IPO | 688.05% |
Recent News & Updates
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?
May 01
DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10
Apr 02Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?
Jan 07Recent updates
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?
May 01DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10
Apr 02Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?
Jan 07These 4 Measures Indicate That DiaSorin (BIT:DIA) Is Using Debt Reasonably Well
Sep 13Are DiaSorin S.p.A. (BIT:DIA) Investors Paying Above The Intrinsic Value?
Aug 17DiaSorin (BIT:DIA) Has A Pretty Healthy Balance Sheet
Jun 14DiaSorin (BIT:DIA) Will Pay A Larger Dividend Than Last Year At €1.05
May 19DiaSorin's (BIT:DIA) Shareholders Will Receive A Bigger Dividend Than Last Year
May 03Calculating The Fair Value Of DiaSorin S.p.A. (BIT:DIA)
May 01DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year
Apr 13DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.05
Mar 21Here's Why I Think DiaSorin (BIT:DIA) Is An Interesting Stock
Mar 02Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 19Is DiaSorin (BIT:DIA) Using Too Much Debt?
Dec 04Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?
Oct 18Is DiaSorin (BIT:DIA) A Risky Investment?
Aug 23Industry Analysts Just Upgraded Their DiaSorin S.p.A. (BIT:DIA) Revenue Forecasts By 12%
Jul 15Here's Why I Think DiaSorin (BIT:DIA) Might Deserve Your Attention Today
Jul 13Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?
Apr 02DiaSorin S.p.A.'s (BIT:DIA) 0.7% Dividend Yield Looks Pretty Interesting
Mar 15Are Institutions Heavily Invested In DiaSorin S.p.A.'s (BIT:DIA) Shares?
Feb 25Returns On Capital - An Important Metric For DiaSorin (BIT:DIA)
Feb 04
Did You Participate In Any Of DiaSorin's (BIT:DIA) Incredible 311% Return?
Jan 14Is Now The Time To Put DiaSorin (BIT:DIA) On Your Watchlist?
Dec 24Are Robust Financials Driving The Recent Rally In DiaSorin S.p.A.'s (BIT:DIA) Stock?
Dec 02Shareholder Returns
| DIA | IT Medical Equipment | IT Market | |
|---|---|---|---|
| 7D | -4.1% | -2.6% | -2.0% |
| 1Y | -20.4% | -4.8% | -11.4% |
Return vs Industry: DIA underperformed the Italian Medical Equipment industry which returned -4.8% over the past year.
Return vs Market: DIA underperformed the Italian Market which returned -11.4% over the past year.
Price Volatility
| DIA volatility | |
|---|---|
| DIA Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in IT Market | 6.8% |
| 10% least volatile stocks in IT Market | 2.6% |
Stable Share Price: DIA is not significantly more volatile than the rest of Italian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: DIA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 3,365 | Carlo Rosa | https://diasoringroup.com/en |
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System.
DiaSorin S.p.A. Fundamentals Summary
| DIA fundamental statistics | |
|---|---|
| Market Cap | €5.29b |
| Earnings (TTM) | €200.31m |
| Revenue (TTM) | €1.29b |
26.1x
P/E Ratio4.0x
P/S RatioIs DIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DIA income statement (TTM) | |
|---|---|
| Revenue | €1.29b |
| Cost of Revenue | €435.43m |
| Gross Profit | €857.71m |
| Other Expenses | €657.41m |
| Earnings | €200.31m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 27, 2023
| Earnings per share (EPS) | 3.74 |
| Gross Margin | 66.33% |
| Net Profit Margin | 15.49% |
| Debt/Equity Ratio | 80.0% |
How did DIA perform over the long term?
See historical performance and comparison